Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interests	Total
Balance at beginning of period at Dec. 31, 2023	$ 944	$ 2,978,852	$ (776,962)	$ 20,042	$ 28,973	$ 2,251,849
Balance at beginning of period (in shares) at Dec. 31, 2023	94,309
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss attributable to common shareholders and noncontrolling interests			(32,276)		(5,380)	(37,656)
Redemption of OP Units for common shares	$ 5	7,870				7,875
Redemption of OP Units for common shares (in shares)	468
Common shares repurchased	$ (30)	(49,414)				$ (49,444)
Common shares repurchased (in shares)	(2,993)					(3,000)
Common shares issued pursuant to employee incentive compensation plan and ESPP		589				$ 589
Common shares issued pursuant to employee incentive compensation plan and ESPP (in shares)	35
Dividends declared on common shares			(16,066)			(16,066)
Contributions from (Distributions to) noncontrolling interests, net					(18)	(18)
Redeemable noncontrolling interests redemption value adjustment and total other comprehensive income (loss) allocation		3,827		(2,026)		1,801
Total other comprehensive income (loss)				14,419		14,419
Other comprehensive income attributable to noncontrolling interests				(1,083)	1,083	(1,083)
Balance at end of period (in shares) at Mar. 31, 2024	91,819
Balance at end of period at Mar. 31, 2024	$ 919	2,941,724	(825,304)	31,352	$ 24,658	2,173,349
Balance at beginning of period at Dec. 31, 2024	$ 846	2,790,403	(997,283)	15,092		$ 1,809,058
Balance at beginning of period (in shares) at Dec. 31, 2024	84,500					84,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss attributable to common shareholders and noncontrolling interests			(45,720)			$ (45,720)
Redemption of OP Units for common shares	$ 7	9,712				9,719
Redemption of OP Units for common shares (in shares)	647
Common shares repurchased	$ (122)	(187,613)				$ (187,735)
Common shares repurchased (in shares)	(12,154)					(12,200)
Common shares issued pursuant to employee incentive compensation plan and ESPP		564				$ 564
Common shares issued pursuant to employee incentive compensation plan and ESPP (in shares)	40
Redeemable noncontrolling interests redemption value adjustment and total other comprehensive income (loss) allocation		(5,951)		1,884		(4,067)
Total other comprehensive income (loss)				(10,827)		$ (10,827)
Balance at end of period (in shares) at Mar. 31, 2025	73,033					73,033
Balance at end of period at Mar. 31, 2025	$ 731	$ 2,607,115	$ (1,043,003)	$ 6,149		$ 1,570,992